Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Alcoholism

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Alcoholism & Liver Cirrhosis Guide Questions:

1. What causes inebriation after alcohol ingestion? 


- Inebriation is synonymous with alcohol intoxication, which is the negative behavior and
physical effects after overconsumption of alcohol or ethanol. This is a physiologic state
wherein it is induced by alcohol consumption. As we all know, ethanol or alcohol is an
inhibitory neurotransmitter and it is believed that it mimics GABA’s effect in the brain, thus,
reducing signal flow in the brain. It also facilitates the operation of inhibitory
neurotransmitters like GABA. That is why this dual effect makes it harder for the brain to do
its normal function.

2. Why are alcoholics susceptible to the development of hypoglycemia?


- When alcohol is consumed, it can inhibit the liver’s ability to release glucose into the blood.
When gluconeogenesis is inhibited, it would eventually leads to hypoglycemia. As we all
know that too much NADH would favor lactic acid production, hence, pyruvate is directed to
undergo anaerobic glycolysis pathways, depleting all pyruvate and none would enter the
Kreb’s cycle, resulting in absence of ATP production.

3. What is the mechanism behind the development of hepatic coma in liver cirrhosis?         
- Hepatic encephalopathy is the impairment of brain function as a result of liver cirrhosis.
This impairment affects behavior, mood, speech, and sleep cycle. Hyperammonaemia plays
the important role in the pathogenesis of Hepatic encephalopathy. The brain-blood barrier
disturbances, changes in neurotransmission, neuroinflammation, oxidative stress, and
benzodiazepine pathway abnormalities are considered to be involved in the development of
Hepatic encephalopathy.
- Hepatic encephalopathy has 4 stages wherein it can lead to hepatic coma when left
untreated. High ammonia levels are toxic to the central nervous system which is why hepatic
encephalopathy may further lead to hepatic coma.
Systemic Carnitine Deficiency Guide Questions:

1. What is the genetic basis for ”systemic carnitine deficiency” (SCD)?

- Systemic Carnitine Deficiency is an autosomal recessive disorder that prevents the body from
utilizing fats for energy production during the fasting state.  

- This disorder is caused by a mutation in the SLC22A5 gene wherein this gene is one that
provides instructions for making a protein called OCTN2 that is found in the heart, liver, muscles,
kidneys, and other tissues. This protein is positioned within the cell membrane and it is important
because it transports carnation into the cell. Once this gene is mutated, this can result in the
improper transfer of carnitine across the cell membrane resulting in urinary carnitine wasting
which will lead to a low plasma level of carnitine and decreased intracellular carnitine
accumulation. Hence, it impairs the entry of long-chain fatty acids into the mitochondrial matrix.
According to Li et al, there are approximately half of the missense mutations while the other half
are composed of splice site, nonsense, and deletion or insertion mutations, which results in
dysfunctional OCTN2 gene product and decreased carnitine transport in various tissues.

2. What is the biochemical basis for the outstanding manifestations of patients with SCD?

* During periods of fasting, our body’s predominant source of energy production is fatty acids. In
patients with Systemic Carnitine Deficiency, there is deficient carnitine, thus, it will result in
defective fatty acid oxidation. When fat cannot be utilized, glucose is consumed without
regeneration via gluconeogenesis resulting in hypoglycemia. In addition to that, there will be
released fat from adipose tissue which will result in the accumulation of fats in the liver, skeletal
muscle, and heart resulting in hepatic steatosis and myopathy.

You might also like